You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

Metastatic Melanoma: The Arrival of LAG3

Read Overview

Supported by an independent educational grant from Regeneron Pharmaceuticals.

                                                                                                                                                                                                          

CME Activities

Metastatic Melanoma: The Arrival of LAG3

LAG3 in Metastatic Melanoma

Resources

Steering Committee

Hussein Tawbi, MD, PhD
Hussein Tawbi, MD, PhD

Steering Committee Chair

Professor
Deputy Chair, Department of Melanoma Medical Oncology
Co-Director, MD Anderson Brain Metastasis Clinic
Melanoma Medical Oncology, Investigational Cancer Therapeutics
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Janice M. Mehnert, MD
Janice M. Mehnert, MD

Professor of Medicine, NYU Grossman School of Medicine
Associate Director for Clinical Research
Director, Melanoma and Cutaneous Medical Oncology
Laura and Isaac Perlmutter Cancer Center at NYU
New York, New York

Michael Davies, MD, PhD
Michael Davies, MD, PhD

Professor and Chairman
Department of Melanoma Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Evan Lipson, MD
Evan Lipson, MD

Associate Professor of Oncology
Johns Hopkins University
Baltimore, Maryland

Krista Rubin, MS, RN, FNP-BC
Krista Rubin, MS, RN, FNP-BC

Nurse Practitioner
Center for Melanoma
Massachusetts General Hospital
Boston, Massachusetts